Premium
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non‐ergot agonists may also not be spared
Author(s) -
Chaudhuri K. Ray,
Dhawan Vandena,
Basu Sumit,
Jackson Gordon,
Odin Per
Publication year - 2004
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.20330
Subject(s) - medicine , valvular heart disease , dopamine , pergolide , cardiology , dopamine agonist , dopaminergic
Abstract Companion letters have been published in this issue of Movement Disorders: Horowski et al., pp 1523–1524 , and Rascol et al., pp 1524–1525 .